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Progressive Evolution or Degeneration?
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Abstract

The published literature on the evidence for a mutational meltdown of life was reviewed. Although
only a small percent of all mutations are detrimental enough to cause disease, the total number
occurring in each generation is signiﬁcant. It was once concluded that the vast majority of all
mutations were neutral, but evidence now exists that indicates no or few mutations are truly neutral
(though most mutations are near neutral). Clearly negative or harmful mutations are often effectively
eliminated from the gene pool, and it is the “near-neutral” mutations that are causing mutational
meltdown. Depending on the speciﬁc set of mutations, near-neutral mutations can accumulate
only to a certain level before they are collectively lethal. It is concluded that the accumulation of
mutations is a major problem for Darwinism because the large number of near-neutral mutations that
are not readily selected out of the gene pool accumulate in each generation, eventually causing
extinction. Mutations, rather then being the engine that drives evolution upward, are, instead, causing
degeneration of the genome. Evolution is occurring, but going the wrong way, as predicted by the
creation model. The reasons why mutations are accumulating in the genome are discussed in some
detail.

Keywords

Mutations, Mutational meltdown, Code degeneration, Near neutral mutations, Species aging,
Extinction

Introduction
Mutations are widely recognized as a major cause
of disease. In a review of the mechanisms that drive
genetic degeneration, Charlesworth and Charlesworth
concluded that “most mutations with observable
phenotypic effects are deleterious” (1998, p. 3).
Estimates vary, but generally, around one new mutation
occurs in “each round of cell division, even in cells with
unimpaired DNA repair and in the absence of external
mutagens” (Meisenberg & Simmons, 2006, p. 153). As
a result, “every child is born with an estimated 100
to 200 new mutations that were not present in the
parents” (Meisenberg & Simmons, 2006). Sanford
(2005) puts the number of point mutations at about
200 and all types total at closer to 1,000.
Of these “an estimated one or two new mutations
are ‘mildly detrimental’,” meaning they do not cause
disease but can impair physiological functions to
some degree, contributing to multifactorial disease
(Meisenberg & Simmons, 2006, p. 153). The result is
that on average every child has “new mutations on
top of those inherited from their parents” causing an
accumulation of mutations, increasing the mutational
load and, eventually, causing genetic meltdown and
extinction (Higgins & Lynch, 2001).
Potential evidence that the mutational genetic load
in humans is increasing includes data recorded in
the standard list of genetic diseases titled Mendelian

Inheritance in Man. The ﬁrst edition listed 1,487
genetic diseases, the current edition over 17,000
(McKusick, 1966, 1998). Several reasons exist for this
dynamic increase, including the recent identiﬁcation of
existing genetic diseases, a larger human population
that allows for more mutations of all types, and
increased medical research in third-world nations.
The increase also reﬂects, in part, a real increase in
the total number of mutations in the human genome
(Bataillon, 2000). This paper reviews the empirical
evidence for this latter conclusion.
Near-Neutral Mutations
The core mechanism of evolution is the occurrence
of mutations that are selected by natural selection—if
the mutation confers a competitive advantage to the
organism (Sanjuán, Moya, & Elena, 2004, p. 8396).
Mutations that have “large deleterious effects” are
often effectively selected out. Conversely, those
“mutations with small effects are . . . less efﬁciently
eliminated from the population” (Sanjuán, et al., 2004).
As a result the “accumulation of weakly deleterious
mutations” produces a “substantial . . . long-term rate
of ﬁtness decline” (Barton, Briggs, Eisen, Godstein, &
Patel, 2007, p. 494). Most mutations were at one time
thought to be neutral, that is, they have no adverse
effects on the organism. As will be discussed, it is
now known that many or most of these mutations are
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not completely neutral, but are actually near neutral
or “very slightly deleterious” for several reasons
(Kondrashov, 1995). No mutation is really neutral if
it causes a deviation from the amino acid set produced
by the original gene because it always results in a
change in the protein’s original amino acid chain.
The neutral mutation concept was considered
a “radical and highly controversial new view of
mutations” when proposed in the 1960s by Motoo
Kimura, (Lowenstein & Zihlman, 1998, p. 190).
However, this view soon became widely accepted
and was assumed to be valid for “the vast majority
of mutations.” The view that neutral mutations
have “little or no effect” on an organism has been
increasingly challenged in recent years. It is now
known that even those mutations that have “little
effect” on health can accumulate, causing major
damage (Ohta, 1998; Sanford, 2005). Furthermore,
evidence has accumulated that many putative
neutral mutations are, in fact, not neutral, including
the mutations in noncoding DNA that was once called
junk DNA (Lowenstein & Zihlman, 1998). Among
the studies that have found mutations in introns that
cause disease (thus having a function) is included an
intron in the calpain-10 gene that is associated with
type II diabetes mellitus (Horikawa et al., 2000)
Research on near-neutral mutations, summarized
by Lynch, Conery, and Bürger (1995b, p. 1067) has
established that it is “now generally accepted that
mildly deleterious mutations arise at a substantial
rate in most higher organisms, probably as frequently
as one per gamete”. The number of known near-neutral
mutations is enormous (Eyre-Walker, Keightley,
Smith, & Gaffney, 2002). In human hemoglobin alone,
close to 800 structural variants have been identiﬁed,
most due to a single amino acid substitution and most
of which are near neutral (Meisenberg & Simmons,
2006, p. 163). The number of existing mutations
that do not cause protein structural variations are
unknown, but the number is probably many times
greater than those that cause structural changes.
Also, known structural variations may be caused by
more than one mutation.
Why Neutral Mutations are not Neutral
Some of the neutral mutations studied were those
occurring in non-coding DNA, often called junk DNA.
Coding DNA consists of only an estimated one to
three percent of all DNA, or about one inch of the six
feet of DNA in each human cell (International Human
Genome Sequencing Consortium, 2004; Meisenberg
& Simmons 2006). It is now widely acknowledged
that many mutations in the alleged “junk” DNA are
not neutral because much of it serves some function,
including regulation, the assembly plans, and the
control systems of the cell and the entire organism.
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Evidence for the importance of noncoding DNA is
that it is highly conserved, indicating that much—or
most of it—is functional (Gibbs, 2003).
It was once thought that these mutations were largely
neutral. For example, components of the blood clotting
system called ﬁbrinopeptides function as spacers to
keep the sticky molecular surfaces apart until a clot is
required. The spacers are then removed and recycled,
allowing the active protein form to exist. Though they
function only as spacers, their speciﬁc composition can
affect the clotting system effectiveness. Experimental
evidence has found that the former conclusion that
almost any amino acid will perform a spacer function
equally well is incorrect for several reasons, including
that certain amino acids can interfere with proper
folding (Minshull, Ness, Gustafsson, & Govindarajan,
2005). Mildly deleterious mutations in mitochondrial
and chloroplast genomes, and also in transfer RNAs
(tRNAs) and ribosomal RNA, gradually accumulate
in the genome, and both contribute to mutational
meltdown (Lynch & Blanchard, 1998, p. 29). This
accumulation has been documented in a wide variety
of life-forms including animals, plants, fungi, and
prokaryotes (Lynch & Blanchard, 1998).
Synonymous Codons
Another major mutation group once felt to be
neutral is a class called “synonymous” mutations.
One example is the putative neutral mutation that
changes a codon, such as UCU which codes for serine,
into a new codon, including UCC, UCA, and UCG,
each of which are also translated into serine. The
translation occurs because of the so-called wobble
effect caused by the common third base redundancy.
As many as six codons will produce the same amino
acid, and most amino acids can be coded by at least
three synonymous codons.
The new wobble codon is rarely lethal, but it is often
slightly less effective. One reason why it is less effective
is the fact that tRNA production levels often correlate
with the original codon requirements, and a change
causes tRNA supply imbalance problems.If a cell rarely
uses a speciﬁc codon, it produces lower levels of the
tRNA needed for that codon (Clark & Russell, 1999,
p. 220). For this reason, a strong positive correlation
exists between codon usage levels and tRNA content
in a given organism (Ikemura, 1985). Consequently,
athough the protein produced does not change, cellular
efﬁciency does. This problem, called codon usage bias, in
which a certain codon from the functional set is favored,
is clear evidence for non-neutrality of synonymous
substitutions. Another ﬁnding is that synonymous
substitutions can change the structure and function of
the ﬁnal protein (Minshull et al., 2005).
Further evidence that codon mutations are not
neutral includes the fact that genes with high
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codon usage bias “have lower rates of synonymous
substitution between species then do genes with low
codon usage bias” (Powell & Moriyama, 1997, p. 7785).
An example is lysine, which can be coded by AAA or
AAG. In E Coli, the AAA codon is used 75 percent of
the time, and in rhodobacteria the opposite is true—
AAG is used 75% of the time. If a gene with a large
number of AAA codons for lysine is transfected into a
cell that almost never uses the AAA codon, its tRNA
is then in such short supply that protein synthesis
for that gene will slow down signiﬁcantly (Clark &
Russell, 1999, p. 220). This indicates that both tRNA
regulation and the genetic code must have been in
place simultaneously in order for the cell to function.
Another example of non-neutral mutations are the
six different codon triplets that code for leucine in E.
coli, 49 percent of which are CTG; in yeast 10 percent
of leucines use this code compared to 44 percent in
the fruit ﬂy and 41 percent in humans. This effect is
another example of codon usage bias where a cell uses
a particular codon only rarely: it produces lower levels
of tRNA for that codon. In almost every organism
studied so far, codon usage bias exists for a particular
codon for each amino acid (Eyre-Walker et al., 2002;
Ikemura, 1985; Moriyama & Hartl, 1993).
Codon usage bias, which is one example of nonneutral mutations that can have long-term deleterious
effects, does not conform to neo-Darwinian
predictions. If certain codons from the functional set
were not favored, that is, if the proportion of codon
usage were the same for all bacteria (which it is not),
this could be seen as evidence for evolution. But we do
not see evidence of a neo-Darwinian relationship in
this pattern; in fact, we often ﬁnd that two organisms
judged close by evolutionary phylogeny do not have a
similar coding usage bias compared with those judged
phylogenetically distant.
Neo-Darwinists argue that the codon evolved ﬁrst,
and the tRNA regulation system evolved later. But
it could just as well be argued that tRNA regulation
developed ﬁrst, and this inﬂuenced the protein codon
selection so that more of certain tRNAs inﬂuenced the
codon used by that tRNA to become more common.
Nonetheless, no evidence exists that a change has
occurred historically in either codon frequencies or in
tRNA regulation.
The codon usage bias level varies among organisms.
For some amino acids in some organisms, its effect
is large enough to impact the animal’s survival.
Research indicates that, with the exception of aspartic
acid, most amino acids contribute signiﬁcantly, and
about equally, to the codon usage bias effect (Powell
& Moriyama, 1997, p. 7784). As these near-neutral
mutations accumulate, overall cellular efﬁciency
slowly declines, resulting in an overall negative effect
on the ﬁtness of an organism.

101
Founder Mutations
Other evidence for a mutational meltdown
includes founder mutations (Drayna, 2005). Founder
mutations are disease-causing mutations that are
not effectively eliminated by natural selection. As a
result, the mutation persists in the population and
can even become widespread, such as the mutation
responsible for sickle cell anemia (Biswas, 2006).
The ancestor that suffered the ﬁrst mutation,
introducing the mutation into the gene pool, is known
as the “founder.” Although often lost in history, some
founders have been traced to a general geographical
location. The most studied founder mutations have
been traced to speciﬁc populations such as the Amish,
Jews, Dutch, and Gypsies (Ben-Yosef & Friedman,
2003; Jääskeläinen et al., 2004; Levine et al., 2003;
Navarro & Teijeira, 2003; Zeegers, van Poppel,
Vlietinck, Spruijt, & Ostrer, 2004).
Documented cases of founder mutations include
certain forms of holocarboxylase synthase deﬁciency
disease (Suzuki, Yang, Aoki, Kure, & Matsubara,
2005), mucolipidosis type IV disease (Bach, 2005),
hereditary nonpolyposis colorectal cancer (Guillem,
2004), early-onset Parkinson’s disease (Hedrich et al.,
2004); familial Mediterranean fever (Touitou, 2001) of
which ﬁve founder mutations account for all 74 cases
studied; Hermansky-Pudlak Syndrome (Huizing &
Gahl, 2002); BRCA1 and 2 ( Liede & Narod, 2002;
Lonning et al., 2001; Rubinstein, 2004;) hypertrophic
cardiomyopathy (Jääskeläinen et al., 2006),
hereditary paraganglioma (Baysal, 2004), CriglerNajjar Syndrome, and canavan disease (Surendran,
et al., 2003). Yet another is factor V Leiden, an
important risk factor in various thromboembolism
diseases (Rees, Cox, & Clegg, 1995).
The study of founder mutations has proven
important in a variety of genetic studies (Rosenberg,
2003). Founder mutations are most likely to persist in
the population if the mutation is recessive, especially
if a recessive copy can confer some advantage to the
carrier, such as is the case with sickle cell anemia and
cystic ﬁbrosis disease, in which a CTT deletion accounts
for virtually all cases of the disease in humans.
Several founder mutations can contribute to
one disease. For example, at least ﬁve different
haplotypes exist for sickle cell anemia, lending strong
evidence to the hypothesis that at least ﬁve founders
exist (Allison, 2002, p. 285). Another good example
is hemochromatosis, caused by a mutation on the
HFE gene on human chromosome six that disrupts
the iron regulation system. This causes excessive
iron absorption, eventually leading to organ damage
and even death if not treated. The mutation evidently
originated in central Europe about 65 generations
ago, and is now present in at least one of the two HFE
genes in an estimated 22 million Americans.
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Many founder mutations persist because they do
not affect the victim until after childbearing years.
An example is the trinucleotide repeat disorder called
Huntington’s Disease, a condition that now affects
many thousands of persons. Traced back to at least
1630, it is now known, thanks to the work of Dr.
Nancy Wexler, that the gene was brought by a few
individuals to both North and South America. Because
it is a dominant gene, on average it affects about
half of all offspring of couples, of which at least one
partner is a carrier. This neurodegenerative disease
causes gradual dementia, uncontrolled movements,
and eventually death (Duyao et al., 1993).
The symptoms of Huntington’s Disease usually do
not show up until after the fourth or ﬁfth decade of
life, after normal reproductive years are past. Many
carriers, due to genetic testing, are now aware they
have the gene in their family. Some victims, knowing
that about half of their children will develop the
lethal disease, still elect to have children. Founder
mutations are signiﬁcant examples of deleterious
mutations because before these mutations entered the
human genome, the diseases they cause did not exist.
As founder mutations accumulate in a species, the
accumulation contributes to the degeneration of the
genome, especially a problem for those species with
small population sizes (Keightley & Eyre-Walker,
2000; Sanford, 2005).
Genetic Drift and Interbreeding Depression
Another problem contributing to genetic meltdown
is random genetic drift that allows near-neutral
mutations to spread to an entire population,
increasing the probability of the “extinction of
the whole population, or the degeneration of nonrecombining portions of the genome” (Charlesworth
& Charlesworth, 1998, p. 3). This is especially
problematic in both small populations andpopulations
that would typically outbreed but do not for forced or
self-imposed reasons, such as the Amish, a religious
group that is known to suffer from a large mutational
load. As a result from founder mutations, the Amish
“experience an inordinately high incidence of certain
genetic-based diseases,” many of which are fatal or
disabling (Shachtman, 2006, p. 24). An example is
Crigler-Najjar syndrome, a genetic disorder that is
caused by high levels of bilirubin, which produces
severe jaundice, resulting in brain damage and death.
The speciﬁc cause is a damaged liver enzyme that is
part of the metabolic breakdown pathway of bilirubin.
Worldwide, fully 20% of all cases are found in the tiny
Amish population (Morton, et al., 2003).
Selection reduces their mutational load—Amish
families often lose one or more children to genetic
diseases—yet the mutational load keeps increasing.
Often genetic diseases, such as many metabolic
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disorders, can be treated, allowing those so afﬂicted
to reach the age of sexual maturity and pass the
mutations on to their offspring. In 1988, three dozen
major genetic diseases were identiﬁed among the
Amish; now fully ﬁve dozen are known (Shachtman,
2006, p. 28).
Are Polymorphisms Just Variety?
Another example of deleterious mutations is
certain genes that were all once assumed to be an
example of normal variety. Some or possibly many of
these genes called polymorphisms (about one percent
of the genome) may be near neutral or even harmful
mutations and not just normal variations (Nachman,
1998, p. 61). As more polymorphisms are researched,
it has been found that some examples once regarded as
normal variations are mildly deleterious. For example,
blue-eyed and fair-skinned persons are signiﬁcantly
more prone to skin cancer, even in environments
where it was assumed that these traits were important
in survival, such as locations where an increased
vitamin D production is beneﬁcial. Blue eyes are
caused by lack of pigmentation on the iris, and blueeyed persons are more prone to certain eye problems,
such as difﬁculty working in bright environments,
retinal pigment epithelial depigmentation, and other
vision problems (Acosta, Alfaro, Borras, Belmonte,
& Gallar, 2006; Singh, Rennie, Seregard, Giblin, &
McKenzie, 2004; Tomany, Klein, & Klein, 2003).
Redundancy in Life
Yet another reason why most mutations are
rarely (if ever) neutral is because of the redundant
systems in most life-forms. Survival, at least to the
point of reproduction (the key to natural selection), is
rarely affected in cases where a backup organ exists
(the phenomena of organ redundancy). Humans
can normally survive quite well without tonsils,
adenoids, spleen, appendix, one kidney, or a lobe of
the liver, allowing mutations that affect these organs
to be passed on to one’s offspring and become part
of the human genome. If a mutation damages an
organ, redundancy allows a considerable number of
mutations to accumulate that will only be weakly
selected against.
Another redundancy factor is the fact that all
sexually reproducing organisms possess two copies
of most genes. If one gene mutates, the other allele
on the sister chromosome can produce the correctly
folded protein. The single copy condition allows
mutations to accumulate because the mutation that
is not effectively selected out if the other gene can still
perform the sister gene’s function. This redundancy
allows damaged genes to accumulate in the genome,
contributing to the mutational meltdown problem.
If humans were haploid, a normal gene mate would
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not be present to compensate for a damaged gene,
and the affected person would be more likely to die
early without passing genes on to offspring. As these
near-neutral mutations accumulate, the strain on the
system increases.
Although redundancy often allows survival,
heterogeneous mutations can affect dosage levels,
requiring compensation. Recessive mutations may
also damage the working unit. For example, the p53
transcription factor is a tetrad of four p53 proteins,
and if even a single protein in the tetrad is damaged,
the transcription factor will not function. Despite this,
recessive germline p53 mutations are often not lethal
until after having children. Familial p53 mutation
patients (Li-Fraumeni Syndrome) usually die of
cancer but can live into, and even past, childbearing
age, allowing them to pass the mutation on to their
offspring (Vogelstein & Kinzler, 1998, pp. 398–399).
Redundancy is not always an advantage, such as is
the case with triplet repeat expansion disorders and
possibly some co-dominance genetic conditions.
The fact that most known human genetic disorders
are recessive explains how the mutations are passed
on to the next generation. Some well-known examples
include cystic ﬁbrosis, sickle cell anemia, and TaySachs disease. Since a person must have both genes
in order to have the disease, only a small portion of
the affected population will die from the disease,
allowing others with the mutation to pass it on.
Evidence for this conclusion is the high frequency
of many recessive mutations in the population. For
example, among Greeks, factor V Leiden is present
in around 7% of the population (Rees, Cox, & Clegg.
1995, p. 1133). Cystic ﬁbrosis strikes thousands each
year; about one in every 20 Caucasian Americans (a
total of 12 million persons) is a carrier of an abnormal
CF gene; most are unaware that they are carriers.
Among blacks, about 7.8% are sickle cell anemia
carriers, and about 0.15% actually have sickle cell
disease (data from NIH Publication No. 95-3650).
Lethal Mutations that have
Selective Advantages
Lethal or deleterious mutations are actually
selected in certain circumstances. The most common
examples actually encourage the spread of lethal
mutations, contributing to the accumulation of
mutations in the genome. The classic example of a
generally harmful mutation that can have a beneﬁcial
effect in speciﬁc situations is sickle cell anemia
(Ridley, 1996, p. 118). The homozygous form is lethal,
causing approximately 100,000 deaths annually, but
the heterozygous form provides a survival advantage
where malaria is common. The heterozygote form,
although it causes anemia, does not result in a level
of sickling that signiﬁcantly affects blood circulation.
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For this reason the mutation is said to be latent.
If the malaria parasite Plasmodium falcipurum
infects an erythrocyte, the victim with a heterozygote
mutant form is more likely to survive. It has been
well documented that persons with one damaged
gene survive better in areas of the world where the
malaria parasite is common. The parasite feeds on the
hemoglobin molecule, causing the oxygen concentration
in the cell to decline, resulting in sickling of the infected
cell. Sickling in turn causes that cell (and the malaria
parasite in it) to be destroyed by the spleen (Ridley,
1996, p. 118). Many other examples of heterozygous
mutations exist that provide a selective advantage in
limited conditions but would be selected out in most
circumstances. Examples include some thalassemia
herterozygotes, which provides an advantage against
malerial parasites as does the sickle cell allele; the
CCR5 deletion, which gives some protection from
AIDS; and glucose-6-phosphate dehydrogenase
variant (G6PD-Mediterranean). G6PD deﬁciency, a
condition characterized by severe enzyme deﬁciency,
but confers some resistance to falciparum malaria.
(Beutler, 1996; Kurdi-Haidar et al,1990).
Methylation of DNA
Methylation of DNA is a major means of controlling
gene expression. Methylation is used for signiﬁcant
genetic regulation to achieve cellular differentiation
and dosage compensation, such as lyonization in
females, which silences one X chromosome. Speciﬁc
methylation sites are a heritable phenomenon that
selectively reduces gene expression by increasing the
binding of repressors. Alterations of methylation sites
can be passed on to future generations and therefore
contribute to the degeneration of the genome.
Methylation is also a major means of causing gene
imprinting to achieve sexual differentiation by turning
off one set of somatic genes in males and another set in
females (Baysal, 2004). Changes in methylation can
adversely affect all of these critical genetic functions.
Disruption of methylation is not effectively repaired,
allowing loss of this epigenetic means of control to
accumulate and, in time, contributing to genetic
meltdown.
CpG islands are a region of 1–2 kb sequences
containing a high density of methylated cytosine
residues. In plants, fungi, and animals, it is the
cytosines are usually methylated, but in bacteria
the adenosines are normally methylated (Turner,
2007, p. 214). In plants, the methylated sequence is
... CpNpGp ... where N can be any base. CpG islands
are a site of high mutational frequency because
spontaneous deamination of the methylated cytosine
5-methylcytosine results in thymine, which is not
recognized by DNA repair enzymes and unrepaired,
resulting in genomic degradation (Coulondre, Miller,
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Farabaugh, & Gilbert, 1978). Approximately 5% of
vertebrate DNAs consist of 5-methylcytosines, and
with time more and more conversion of C to T occurs
by this process.
Modern Medicine
Modern medicine can contribute to genetic
degeneration because it may allow children that have
lethal mutations to live long enough to reproduce,
increasing the human mutational load. The mutational
load is thus reduced by natural selection and increased
by modern medicine. Historically in many societies
as many as half of all children died before they were
old enough to reproduce. Those who died had, on
average, not only more detrimental mutations, but
also more near-neutral, detrimental mutations than
those who survived. Medicine, antibiotics, and better
nutrition and sanitation have reduced this death rate
signiﬁcantly (Meisenberg & Simmons, 2006, p. 153).
Darwin recognized this concern and for this reason
opposed vaccinating because the procedure
has preserved thousands, who from a weak
constitution would formerly have succumbed
. . . . Thus the weak members of civilized society
propagate their kind . . . this must be highly injurious
to the race of man. It is surprising how soon a
want of care, or care wrongly directed, leads to the
degeneration of the domestic race . . . we must bear
without complaining the undoubtedly bad effects
of the weak surviving and propagating their kind

(1871, pp. 168–169).
Although Darwin’s example is incorrect because
infectious disease effects largely those with weak
immune systems or those who lack resistance), his
point is valid with many diseases. This point does not
condemn the use of modern medicine as Darwin did,
but recognizes the fact that an unfortunate side effect
is that medicine has reduced enormously the infant
mortality rate, allowing persons with detrimental
mutations to have offspring and pass them on to
future generations. Lynch, et al., opines that with
animal life the problem of deleterious mutation
accumulation may be exacerbated in endangered
species that are conﬁned to breeding facilities. Since
captive environments are usually quite benign
(including services from dietitians, veterinarians,
artiﬁcial inseminators, etc.), a real possibility exists
that mutations that are signiﬁcantly deleterious in
nature are rendered nearly neutral. If that were the
case, regardless of the population size, deleterious
mutations would accumulate at nearly the neutral
rate, µ/2 per generation, although their effects would
go undetected until the population was reintroduced
into the wild. At that point, the population might no
longer be capable of sustaining itself without continued
human intervention (Lynch, 1996, p. 489).
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Mutations Compensated for by
Dietary Alterations
An important class of mutations are those that
damage an enzyme, a metabolic pathway, or a mediated
transport system that moves materials across a cell
membrane. Many of these mutations cause diseases
that can be successfully treated by dietary changes,
allowing the patient to survive and pass the mutation
on to their progeny. The most well-known example
is phenylketonuria (PKU), a metabolic disorder
that results in the buildup of toxic byproducts from
the defective breakdown of phenylalanine. PKU is
successfully treated by a rigid dietary restriction of
phenylalanine, an essential amino acid (Meisenberg
& Simmons, 2006, p. 494).
Newborn screening for PKU is mandatory in
many countries. The disease, which, depending
on the mutations involved, normally causes severe
retardation, seizures, spasticity and other neurological
problems that prevent the victim from passing the
mutation on to offspring. However, by following
dietary restrictions, PKU patients now develop
normally and can freely pass the mutation on to their
offspring (Meisenberg & Simmons, 2006, p. 494).
Although phenylalanine is nutritionally essential
in small amounts, it can be greatly reduced by such
dietary restrictions such as avoiding the artiﬁcial
sweetener aspartame and other foods and condiments
that contain large amounts of phenylalanine without
adverse health effects. Again, the human and proper
response has unintended undesirable side effects.
Some other examples of the many known metabolic
diseases caused by mutations include trypsinogen
deﬁciency treated by dietary supplementation of
protein hydrolysate and celiac disease treated by a
gluten-free diet (Frezal & Rey, 1970, pp. 287–288).
Gluten, found in wheat, rye, and barley, can be avoided
by not eating foods containing these grains. Other
examples include milk protein intolerance treated
by complete avoidance of cow’s milk. Depending
on the speciﬁc mutation involved, the problem is
often an inability to process casein and lacto-serum
proteins. Another example is sucrose and isomaltose
intolerance, usually treated simply by removal of
sucrose and starch from the diet. Most of these
diseases are lethal if not treated, and the cause of
most of them was unknown until recently (Frezal &
Rey, 1970, p. 306).
Mobile Elements Damage the Genome
Much of our genome is currently believed to
contain what is often, and probably incorrectly, called
“parasitic DNA,” which are a result of what is known as
jumping genes or—more formally—mobile elements.
How many of the mobile elements cause damage
is not known, but the fact that the DNA in our 46
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chromosomes, some conclude, contains an estimated
three million mobile DNA segments indicates the
damage may not be minor. This mobile DNA includes
retroviruses—a type of retrotransposon similar
to the AIDS virus. Other examples include Long
Interspersed Elements (LINES) or Short Interspersed
Elements (SINES). Research evidence indicates that
some retrovirus LINES and SINES have vigorously
colonized the DNA of mammals. LINES use two
genes of their own, and SINES, which do not have
genes to splice themselves into the genome, must
instead hijack the enzymes of other putative parasites
in order to copy and paste themselves into new DNA
sites (Kazazian, 2004, p. 1626). Even if most all of
the parasitic DNA is found to have a use, the small
amount of misplaced or actual parasite DNA could do
a signiﬁcant amount of damage.
These mobile elements normally insert themselves
into DNA at selective sites but sometimes insert
themselves at other sites, disrupting a gene and causing
a mutation. An estimated one in every 200 babies has
inherited a new damaging putative parasitic element,
and one in every 1,000 patients has a new genetic
disease as a result of a misdirected mobile element
that has disrupted an important gene (Ostertag &
Kazazian, 2001; Deninger & Batzer, 1999; Ostertag,
Goodier, Zhang, & Kazazian, 2003). Assuming that
these estimates are correct, this damage will result
in a signiﬁcant increase in the mutation load.
Some cancer-causing viruses also splice themselves
at random sites into human DNA. When a particular
viral DNA section is found at the same position in
the DNA in every cell in a cancer tumor, all of those
cells are believed to be descended from the cell in
which the unique viral insertion occurred—the
founder mutation (Ng, Guan, Poon, Fan, & Lee, 2003;
Tsukaski, Koefﬂer, & Tomonaga, 2000). Some common
examples include papilloma viruses, hepatitis, and
some forms of leukemia. Founder mutations caused
by mobile element insertion errors are not reversed by
any known dedicated mechanism, and, unless lethal
before reproduction, they accumulate in the genome,
contributing to genetic degeneration.
Another example is the Alu elements that are
ampliﬁed by retrotransposition, an RNA-dependent
mechanism. Although they are believed to be
functional in humans, they continue to accumulate
at the rate of one insertion for every 200 new
births (Deininger & Batzer, 1999, p. 183). At least
16 new diseases have been identiﬁed as being
caused by new Alu elements, including hemophilia,
neuroﬁbromatosis,
chlorinesterase
deﬁciency,
glycerol kinase deﬁciency and several cancers
(Deininger & Batzer, 1999, p. 184). Alu elements
alone may cause as much as 0.4% of human genetic
disease. Another major mobile unit of DNA is the L1
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element, which is much longer then Alu elements. L1
elements can also supply the needed components for
Alu retrotransposition.
Tandem Repeat Expansion Disorders
Many genes consist of repeats of sets of three or
more bases called tandem repeat bases. They tend
to be mutational hot spots (Sutherland & Richards,
1995). The “length of tandem repeats is prone to
change through mutation,” and in each generation they
can increase, a problem called stuttering, eventually
causing disease because the expanded protein forms
abnormal complexes with other proteins (Meisenberg
& Simmons, 2006, p. 127). For example, Huntington’s
disease is caused by an expansion of the CAG
trinucleotide repeat. CAG is normally repeated from
6–34 times and causes disease if it expands beyond 36
repeats. The repeat often expands in each generation,
and the more it expands, the earlier the onset of the
disease. Other common examples of tandem repeat
disorders are fragile X syndrome, Friedreich ataxia,
and myotonic dystrophy (Campuzano, et al. 1996;
Hagerman & Cronister, 1996; Mahadevan, M., et al.
1992)
Pseudogenes
Evidence indicates that many pseudogenes are
damaged genes. For example, most animals (except
humans, apes, monkeys, fruit bats, several species of
ﬁsh, and guinea pigs) can manufacture an enzyme
that is critically important in vitamin C production.
The L-gulono-gamma-lactone enzyme catalyzes
the last step of vitamin C synthesis (Nishikimi,
Fukuyama, Minoshima, Shimizu, & Yagi, 1994).
Lack of about 60 mg of vitamin C daily in humans
leads to serious health problems, including scurvy,
which has historically been a major killer.
Humans possess all of the enzymes required to
manufacture vitamin C except L-gulono-gammalactone (Inai, Ohta, & Nishikimi, 2003). A pseudogene
that is about 70% similar to the functional gene
exists that appears to be a damaged L-gulonogamma-lactone gene. Speciﬁcally, it lacks critical
control sequences, such as the promoter, required
to transcribe the gene (Zhang, Harrison, Liu, &
Gerstein, 2003). The human pseudogene has four of
the 12 exons of a similar functional L-gulono-gammalactone gene in the rat. These four rat exon sequences
have 70–80% homology to the human pseudogene.
If this pseudogene is, in fact, a damaged functional
gene, its loss has resulted in an enormous number
of human deaths. Of the thousands of pseudogenes
believed to exist, no doubt, some do have a function,
such as for genomic regulation, but it is likely that
some are damaged functional genes. No one knows
how common pseudogenes are, and estimates vary
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widely, but they are believed to be very common.
Gerstein and Zheng claim that they “litter our
chromosomes” (2006, p. 49). This is evidence for a
genetic meltdown instead of the genetic build-up that
is required by evolution.
Genetic Meltdown Evidence
These few examples illustrate why the
accumulation of near-neutral mutations contributes
to the “mutational meltdown” problem, eventually
causing extinction (Lynch, Conery, & Bürger, 1995a,
b; Eyre-Walker & Keightley). As early as 1964 Muller
proposed that even very large populations of asexual
organisms would inevitably accumulate deleterious
mutations (Barton, Briggs, Eisen, Goldstein, & Patel,
2007, p. 681). Muller concluded that the result would
be a gradual ratchet-like increase in mutations,
eventually causing the extinction of the organism, an
effect called “Muller’s ratchet” (Muller, 1964).
Muller concluded that the accumulation of
deleterious mutations eventually results in the
extinction of even the most ﬁt organisms. This
problem is most serious in asexual organisms and is
exacerbated by both a high mutation rate and small
populations. The reason is “in the absence of sex,
deleterious alleles accumulate” because sex produces
recombination as a result of genes from each parent.
Furthermore, all
populations must continually eliminate deleterious
mutations if they are to survive. This elimination
is much more efﬁcient if there is recombination . . . .
[T]he primary function of sex and recombination may
be to prevent the fatal accumulation of mutations.
Because all organisms suffer a mutation load, this is
an attractive general explanation for the prevalence of
sex and one that has received much attention in recent
years. Sexual reproduction can reduce the mutation
load . . . . If mutation is always from good alleles to bad
(a reasonable approximation) then the ﬁtness of an
asexual population is reduced . . . if there is negative
epistasis, so that the effect of each additional mutation
becomes more severe as the number of mutations
increases, then negative linkage disrequilibria will
be generated. Recombination breaks these up and, by
doing so, can substantially reduce the mutation load.
This gives a population-level advantage for sexuals
over asexuals (Barton, et al., 2007, p. 680).

In a typical study of the mutational load problem
that examined 1,700 generations, Andersson and
Hughes found 1% of the 444 lineages of a DNA based
microbe studied “had suffered an obvious loss of
ﬁtness” (1996, p. 906; Nachman & Crowell, 2000).
The researchers concluded that genetic mechanisms
in asexual populations, such as back mutations or
compensatory mutations, “cannot compensate for the
accumulation of deleterious mutations” (1996, p. 906).
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Lynch et al. concluded that, although it is “widely
acknowledged that the gradual accumulation of
mildly deleterious mutations is an important source
of extinction for asexual populations,” evidence now
exists to support the conclusion that the gradual
accumulation of near-neutral mutations causes the
same result in sexual populations (1995b, p. 1067).
They add that computer simulations supported by
analytical approximations
indicate that mutation accumulation in small,
random-mating monoecious populations can lead
to mean extinction times less than a few hundred
to a few thousand generations . . . . Under all mating
systems, the mean time to extinction increases
relatively slowly with the logarithm of fecundity,
and mutations with intermediate effects (similar to
those observed empirically) cause the greatest risk of
extinction” (Lynch et al., 1995a, p. 1067).

A study of the mechanisms that purged ﬁxated
deleterious genes noted that “a large fraction of
mutations” are “unconditionally deleterious” (Lynch,
1996, p. 483). Lynch added that the “accumulation of
deleterious mutations” inﬂuences the mean ﬁtness
and extinction risk, especially of small populations.
He concludes that the “worst-case scenario is realized
when the size of the founder population is so small
that random genetic drift completely overwhelms
the power of natural selection” (1996, p. 486).
Slightly deleterious and near-neutral mutations
also accumulate in mitochondrial DNA. Evidence
now exists that “many mitochondrial amino acid
polymorphisms are deleterious” (Nachman, 1998,
p. 67). Random factors and genetic drift are also
important. Barton et al., conclude
any kind of selection causes random ﬂuctuations
at linked loci, which may by chance ﬁx deleterious
mutations. This effect is especially severe in strictly
asexual populations . . . even in a very large asexual
population, deleterious mutations must accumulate
[and even] . . . the ﬁttest genotype can be lost by
chance, and once lost, it can never be recovered . . . .
[T]he whole population must trace its ancestry back
to the ﬁttest class . . . . Once the ﬁttest class is lost,
the process begins again, but with all individuals
carrying one extra mutation. Even if the population
size is in the millions, weakly selected mutants will
still accumulate (Barton et al., 2007, p. 687).

Mutation Rates
To assess the contribution of near-neutral mutations
to the mutational meltdown problem, understanding
the rate of mutations is critical (Crow, 1997; Neel et. al.,
1986). The rate that mutations are expressed depends
on a wide variety of factors, and this is one reason why
the mutation rate can only be estimated (Kondrashov,
1998). For example, the mutational expression rate is
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higher in cases of self-fertilization and inbreeding,
but lowed when synergistic epistasis. is involved.
Epistasis refers to the interaction between genes:
synergistic is a positive interaction (higher expression
of the trait), antagonistic a negative interaction
(lower expression of the trait). Charlesworth and
Charlesworth conclude that the mutation rate is so
high that highly inbreeding species are expected to
have a short existence (1998, p. 15).
Andersson and Hughes found a deleterious
mutation rate of 0.3 to 1.5 mutations per billion base
pairs per generation in Salmonella typhimurium,
which they characterized as having a “typical
genomic mutation rate” for bacteria (1996, p. 906).
Work on Drosophila suggests a rate of 0.5 mutations
per generation that causes a reduction of ﬁtness by
one to two percent per generation (Charlesworth &
Charlesworth, 1998, p. 15). This number is signiﬁcant
because bacteria and fruit ﬂy generations consist of a
matter of minutes or days. In the laboratory “rates
of spontaneous mutation per genome as measured in
the laboratory are remarkably similar within broad
groups of organisms, but differ strikingly among
groups” (Drake, Charlesworth, Charlesworth, & Crow
1998, p. 1667). They estimated that in microbes the
rate is 1/300 per genome per replication and in higher
eukaryotes from 0.1 to 100 per genome per sexual
generation. For mammals the mutational meltdown
would be expected to take thousands of years.
More recent research that obtained the ﬁrst direct
estimate of mutation rates in complex organisms
found evidence that mutation rates are about 100
times higher than previous estimates (Denver,
Morris, Lynch, Vassilieva, & Thomas, 2000). Most of
these studies ignored what were considered neutral
mutations. The current estimate for all mutations is
approximately one unrepaired mutation occurs for
every one hundred million nucleotides copied each
generation. With three billion base pairs in humans
this equals a minimum of 30 new mutations per
individual (Behe, 2007, p. 11). A literature review by
Sanford (2005) found that the number of mutations
is even higher. Barton et al. concluded that the total
genome-wide mutation number that changes amino
acid sequences is about 0.9 per haploid genome per
generation. If even a small proportion of these were
only mildly deleterious, a signiﬁcant number could
accumulate. Although the “effect of each mutation
would be small, the long-term rate of ﬁtness decline
could be substantial” (Barton et al., 2007, p. 494).
These studies indicate much work is needed in this
area to understand different mutation rates found,
which depend on the organism, where the mutation
occurs in the gnome, the effectiveness of the repair
system, and the effectiveness of natural selection
to remove mutated organisms from the gene pool.
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Nonetheless, the rate is so signiﬁcant that numerous
researchers have explored the obvious question: why
have we not seen a genetic meltdown in all life by
now (Kondrashov, 1995)? A common answer is that
natural and sexual selection both work to slow down,
but not stop, the mutational load increase (Andersson
& Hughes, 1996, p. 907). The genetic meltdown is
proceeding forward, although far less rapidly then
it would if selection and sexual reproduction did not
exist. Meisenberg and Simmons note that the
mutational load is kept in check by natural selection.
In most traditional societies, almost half of all children
used to die before they had a chance to reproduce.
Investigators can only guess that those who died had,
on average, more “mildly detrimental” mutations
than those who survived (2006, p. 153).

Mutational rates are misleading because the
45,000–50,000 detected coding regions in humans
produce over 100,000 different proteins due to
alternative splicing (Bertone, et al, 2004). As a result,
one mutation may result in several defective proteins.
Furthermore, “it is likely that nearly all human genes
are capable of causing disease if they are altered” in
ways that produce defective proteins that affect their
function (2002, p. 1514). The ENCODE project found
that the same is true of mutations in the large number
of regulatory DNA. The near-neutral mutations, and
those that allow the afﬂicted to survive, can add to
the total genetic load of near-neutral and deleterious
mutations. Another factor is over one dozen mutation
repair mechanisms are known to exist, and, no doubt,
more await discovery. Research on persons exposed to
radiation indicates that after several generations, the
repair system and natural selection may reduce the
mutation load. This effect tends to maintain stasis,
an effect that opposes evolution.
Summary
The evidence shows that evolution by means of
mutations, under the inﬂuence of natural selection,
is real but, in the long run, results in degeneration
of genomic information—not in an improvement as
required by orthodox evolution. As Lynch concludes,
assuming back mutations are rare and discounting
the effect of recombination and segregation, a parent
“can never produce an offspring with fewer deleterious
mutations then it carries itself” (1994, p. 1067). The
mutational load will, in general, increase with each
generation, and since most all (if not all) mutations
are either near-neutral or deleterious, the result will
be genetic deterioration, eventually leading to genetic
meltdown and extinction. Direct experimental
genetic evidence of this conclusion has been found in
laboratory research with Saccharomyces cerevisiae
populations (Zeyl, Mizesko, Arjan, & De Visser, 2001).
Both near-neutral and detrimental mutations were
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evaluated, focusing on the reasons why detrimental
mutations were not eliminated by natural selection.
Although only a small portion of all mutations
in eukaryotes is detrimental enough to directly
affect survival, the total number occurring in each
generation is signiﬁcant (Kondrashov, 2002). It was
once concluded that the vast majority of all mutations
were neutral, but evidence now exists indicating that
few mutations are truly neutral: most mutations are
near neutral (Sanford, 2005, p. 72). Clearly harmful
mutations are often effectively eliminated from the
gene pool, and it is the “near-neutral” mutations that
are causing concerns about mutational meltdown of
life because they accumulate in the genome. The most
common example is aging, which is a result of an
accumulation of mutations, but evidence now exists
that the genome itself is also aging (Sanford, 2005).
This review conﬁrmed Sanjuán’s conclusion
that “mutations typically lead to reduced ﬁtness,”
but fortunately, many mutations are “removed by
purifying selection” (Sanjuán et al., 2004, p. 8396).
The problem is the near-neutral mutations—those
that are not lethal and, for this reason, are allowed to
accumulate in the gene pool. As Lynch concludes
what little we know about deleterious mutations raises
the real concern that their recurrent introduction can
threaten the persistence of even moderately large
populations over time scales of several dozens of
generations (1996, p. 489).

This is because many factors intersect. For example,
osteogenesis imperfecta, or brittle bone disease, is
caused by mutations in the genes that make 1 procollagen, both COL1A1 and COL1A2 genes. Although
osteogenesis imperfecta is, in the vast majority of
cases, inherited in a dominant fashion, its penetrance
is variable, meaning the clinical characteristics and
severity vary greatly (Plotkin, 2007). Most victims
survive to adulthood and have families, and many
patients with mild forms may not even be aware of their
condition. Thus, the mutation is commonly passed on
and has become a part of the human genome load.
The disease can effect several organs and even whole
organ systems, disproportionately contributing to
the human mutational breakdown problem (Plotkin,
2007). New mutations introducing the disease in new
genetic lineages are fairly common, resulting in an
increase in the rate of osteogenesis imperfecta in the
population in addition to inherited cases.
Conclusions
The main mechanism contributing to this meltdown
is the “recurrent introduction of new deleterious
mutations in each generation” (Lynch & Blanchard,
1998, p. 29). The accumulation of mutations is a major
problem for Darwinism, mainly because of the large
number of near-neutral mutations that are not readily
selected out of the gene pool. These accumulate in
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each generation, eventually causing extinction. It
was found that certain clearly negative mutations
are not selected out from the gene pool for at least a
dozen reasons, and as a result they accumulate in the
genome. Clear evidence now exists that mutations,
rather then being the engine that drives evolution
upward, instead are causing degeneration of the
genome in harmony with the biblical concept of the
Fall and Curse. Evolution, deﬁned strictly as genetic
change, does occur, and these changes are a critical
component of the creation model that helps to account
for the enormous biological diversity seen in the
natural world today. However, the types of mutational
changes discussed in this review are inconsistent
with the evolutionary idea of common decent from
ancestral protocells.
Science research has proven the following challenge
wrong:
The church teaches that man was created perfect,
and that for six thousand years he was degenerated.
Darwin demonstrated the falsity of this dogma. He
shows that man has for thousands of ages steadily
advanced; that the Garden of Eden is an ignorant
myth . . . and that man did not “fall” (Ingersoll, 1990,

pp. 358–359).
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